摘要
目的:探讨临床药师监护制度在临床抗肿瘤药物应用中的效果,促进肿瘤科合理用药。方法:根据临床药师监护制度实施时间将300例肿瘤科住院患者分为观察组和对照组。观察组(150例)配备专门的临床药师,参与到临床治疗和护理的全过程;对照组(150例)未实施临床药师监护制度。对两组临床用药情况进行分析比较。结果:两组用药均未发生不良事件。观察组不合理用药情况和药物不良反应发生率均低于对照组,差异有统计学意义(P<0.01)。结论:实施临床药师监护制度可提高肿瘤科临床用药的规范性,降低不合理用药和药物不良反应的发生率,对保障患者用药安全具有重要意义。
Objective：To investigate the effect of clinical pharmacist guardianship system on anticancer drug application, and to promote rational drug use in oncology.Methods： 300 cases of hospitalized patients was divided into observation and control groups according to clinical pharmacist guardianship system implementation time. The observation group （150 cases） was equipped with specialized clinical pharmacists who involved in the whole process of clinical treatment and care while there were no pharmacists in the control group （150 cases）. The use of medicines were compared between the two groups.Results： No adverse event occurred in the two groups. The incidence of irrational drug use, adverse drug reactions were significantly lower in the observation group than in the control group （P〈0.01）.Conclusion：The implementation of clinical pharmacist guardianship system could effectively improve the standardization of clinical oncology medication, reduce the incidence of adverse drug reactions and irrational drug uses, which had important implications for patient medication safety.
出处
《药品评价》
CAS
2014年第14期30-31,共2页
Drug Evaluation
关键词
肿瘤科
临床药师
监护制度
合理用药
Oncology
Clinical Pharmacist
Guardianship System
Rational Drug Use
